🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested
This is a Phase 1, open-label, multi-center, competitive enrollment, and do...
Status
Recruiting
Location
James A. Haley Veterans' Hospital
Start Date
2025-08-16
Trial ID
NCT07049328
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
Safety evaluation of combined immunogene therapy in patients with advanced ...
Status
Terminated
Location
Hospital Italiano
Start Date
2020-02-20
Trial ID
NCT03338777
Treatments Being Tested
MIROCALS is a phase II study of ld-IL-2 as a therapeutic agent for ALS. A r...
Status
Completed
Location
CHRU de Lille - Hôpital Roger Salengro
Start Date
2017-06-19
Trial ID
NCT03039673
Treatments Being Tested
The purpose of this study is to find out if the immune systems of HIV-posit...
Status
Completed
Location
Johns Hopkins Hosp
Start Date
2004-05
Trial ID
NCT00001131
Treatments Being Tested
This study is a randomized, placebo-controlled, phase 2a trial to study the...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Start Date
2019-08-07
Trial ID
NCT04055623
The primary objective of this study is to evaluate several interventions gi...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2019-12-19
Trial ID
NCT04129931
Treatments Being Tested
The goal of this open-label, single-arm phase I/II clinical trial is to eva...
Status
Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Start Date
2025-08-01
Trial ID
NCT07123545
A key aspect of the trial is that functions of anti-neoplastic T cells and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT05810792
Treatments Being Tested